SCHEMBL6740723

SCHEMBL6740723

CCC(I)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11659135 0.97
SCHEMBL5326446 0.75
SCHEMBL127420 0.72
SCHEMBL10402953 0.71
SCHEMBL10402743 0.69 PLA2G1B (0.30)
SCHEMBL7871008 0.69
SCHEMBL6417555 0.69
SCHEMBL10403875 0.69
SCHEMBL15789288 0.69
SCHEMBL10403782 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572430-B2 Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-02-07 US disclosed
US-11480877-B2 Resist composition, method for forming resist pattern, and polyphenol compound used therein MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-10-25 US disclosed
US-11243467-B2 Compound, resin, resist composition or radiation-sensitive composition, resist pattern formation method, method for producing amorphous film, underlayer film forming material for lithography, composition for underlayer film formation for lithography, method for forming circuit pattern, and purification method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-02-08 US disclosed
CN-107428646-B Compounds, resins, and methods for their purification, and uses thereof 三菱瓦斯化学株式会社 2021-03-02 CN disclosed
US-8765804-B2 Pharmaceutical compositions comprising lignans and their derivatives for treating hyperplastic diseases UNIVERSITÄT INNSBRUCK (AT) 2014-07-01 US disclosed
US-6680300-B2 FOR CANCER THERAPY BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2004-01-20 US disclosed
US-20030023052-A1 Methods and compositions for the manufacture of highly potent anthracycline-based antitumor agents BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-01-30 US disclosed
CN-1100165-C Improved regenerated collagen fiber and method of manufacturing the same KANEGAFUCHI CHEMICAL IND (JP) 2003-01-29 CN disclosed
EP-0890663-B1 Improved regenerated collagen fiber and method of manufacturing the same KANEKA CORP (JP) 2002-11-13 EP disclosed
WO-2000026223-A9 METHODS AND COMPOSITIONS FOR THE MANUFACTURE OF HIGHLY POTENT ANTHRACYCLINE-BASED ANTITUMOR AGENTS UNIV TEXAS (US) 2002-08-22 WO disclosed
US-6437105-B1 SIDE EFFECT REDUCTION; CYTOTOXICITY; OVERCOMES MULTI-DRUG RESISTANCE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2002-08-20 US disclosed
US-6160096-A Regenerated collagen fiber and method of manufacturing the same KANEKA CORPORATION (JP) 2000-12-12 US disclosed
WO-2000026223-A2 METHODS AND COMPOSITIONS FOR THE MANUFACTURE OF HIGHLY POTENT ANTHRACYCLINE-BASED ANTITUMOR AGENTS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2000-05-11 WO disclosed
CN-1207422-A Improved regenerated collagen fiber and method of manufacturing the same KANEGAFUCHI CHEMICAL IND (JP) 1999-02-10 CN disclosed
EP-0890663-A2 Improved regenerated collagen fiber and method of manufacturing the same Kaneka Corporation (JP) 1999-01-13 EP disclosed